{"name":"Engrail Therapeutics INC","slug":"engrail-therapeutics-inc","ticker":"","exchange":"","domain":"engrail.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ENX-102","genericName":"ENX-102","slug":"enx-102","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ENX-102","genericName":"ENX-102","slug":"enx-102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNUEd6bmFmQWExTlVkNEhNcXFlLVEyem84bVZKT1ZxdXFlbDNuN3FhU1BzWE9hWU5Ja19PZEw3ZDJIWlV0S1NHRFBCVlJSV1NWODJ0M3Zhb2tQUWJpYUVnYk5qS05YYlZ2T2ExNjgwdmRyNkMwNndzbmpFQ1VieWp4YTRGSEFkek9xNjhrUFdWR0ctNE9UdGt1MjF2dTcxa2tQV3ZLTnJ3aWZhclNiTjRwZVBxX0g3NlVaVUFaT0NlOVlrTG1QcFFaMmx3NkFiSlVKWFJiY3FTX1RVLVg1ZHJVSFVYNU1MSS1pc01NOFE2NVZhZHhVVDUxZTVKWmU0SEVWVG9hRW10T3lZZVhLQ1kzODR2T0Z4QncyaGFyVWlNTzdzcWpMMTRUbU9kUU1xVm56VnE0cGVxNzRLQlA5aGdJYmoxbnNUQ3BmWXRJ?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharma, SK Biopharma - Barc","headline":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aques","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPVkozMW1zM3lUY3VDZkxmNGVnU09hVFUyZDRvQ1FITnhHeVR2SjZIdFVGUkZVNmU1SDRxaFZrZ0FRX2N3ekFWdVlwcEREN2xCOHJKaG1zbE5LTnNrODRlWWVyRjVwZ0FWOFhrRFJ4QVhjZzFsa1phYTBDZ3dNUXhjc1VMOGZ4N0ZtcW9oMWxTRmJPMU9Jb1pRTHJBSWMzQjZTWGtsYmZzc2dvOWIy?oc=5","date":"2025-10-20","type":"pipeline","source":"prnewswire.com","summary":"Resistance to Epilepsy Treatments May Wane Over Time - prnewswire.com","headline":"Resistance to Epilepsy Treatments May Wane Over Time","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMW1jb1NCSnFLRVVINXFianoxbTd6Y1lFQ2RNNHJZVzYxb2JUczRzajdPc2d0RVQ2eDlZWENZZ1VSZkZBRUlJSGdKblFNU3ctbkV1MkI0aVdETFctUTZ6TVg0UldXaHVnWGxXcVlkaWdPNnIwa0VXRWN4cVJLYWstOXloQXIyaDNQcDAwYnRNQjVvN3AxaVdBaEt4MEhhT0MzQmc?oc=5","date":"2025-08-25","type":"pipeline","source":"NYU Langone Health","summary":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief - NYU Langone Health","headline":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQX0NMTkpRanlRZFhWQjZFLXg5RjBxTUlRSnVrZkRBeUJXSkZKTUMxNG9xVEk0TWJ0Q0NSdVJDeFU1cE96WEJxVUI4N3J6M0x1NUNjZzZvdU41dTRQTG5IakFkMjhCdVFMYXNWU21UVFcwU3ZaSU5DVXU3NDBpU0c0c1pNR09raUMzaTQwalB4MnpaREJOcm9JZTMtTlhCNmJwWXNodk9wMWZEeXo0b3NyVzVZVEhxNDA?oc=5","date":"2025-07-02","type":"regulatory","source":"Healio","summary":"Psychedelics may improve psychotherapy outcomes, but obstacles remain - Healio","headline":"Psychedelics may improve psychotherapy outcomes, but obstacles remain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxOdGVFLTlnM2pwZGVyTk1WaWxwSFR2dko3SVlxNnhTUHR5aWVLa3Z1STd6RC1ZbkxlbkJRVGFqVmVVSjVfclNiR3lkZGc1UUhITDNJMHJlRkNUVkJyaHk3cVQtYXZoUU9JZjZ2TXpiLVZJQXg3c19OOFdnUDZrcGRVOHRrNjJaMmtoLWtRYkNuREIyYVhVX1dSZjlNamJIM0RjUUlHRFpiUFN5cTAxU0ZZalRUT3cyMG9Kc3ZuUmlOcXo3OTlXNFZqTnJORVNtTFZFcldmTEtfX0U4eEFYYVBCTDc4amJEY1ZZNTZtcFl6b2dsOHNNUG9Ba1AzUFFUQjZVbW54RHBxdGF4eElyN2RqWjd1bXNFY1pGcnVQdEVWRVR5SnRMcE1KRnFFa1I1bUtvVTZ2ckxBNF8tcHVYVUtJU0taUlJNVW9TWHJwVl93?oc=5","date":"2025-03-04","type":"trial","source":"GlobeNewswire","summary":"Dopamine Receptor Antagonists Clinical Trial Pipeline - GlobeNewswire","headline":"Dopamine Receptor Antagonists Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOZUxCMmJiUVNCRlNNNEdsTzJKaGp6VndHVjAtTThCbmtiTzR0RFlYcnRIWjQxUmY2Z1NUTmplY1puWHNvcDBhb0RSUkpxMWhQQTgyUk9uRklIa1ZfZE0tNzJTNDJOQlF4YnlVXzVLc29iQXduQ2JPcWUxOGR1TGw4TTVpTEI1Y3FxZ2c?oc=5","date":"2025-02-13","type":"pipeline","source":"BioPharma Dive","summary":"A brain biotech launches with Roche’s spare parts - BioPharma Dive","headline":"A brain biotech launches with Roche’s spare parts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOWmlmTW1FdjdTbVp6ZWhkMDdsTUo4TmlYTEFnaDFGTEVvRW9fV2pJRUVwVDRIbHhjWHhxNTVpVm5XdTBmS1gtWmN0UVB0Y0xsbTRUaW9jc0VLYjhTQ2MzMnhOSFU4ZEFCVmRBbUh5M08xNklETnV1dUNfMHZ2UU93eUJWMXN3Z2F2Z0lKZ2h2ZDZvWlZNR3Y2Y1RhXzRLX0lxMnRzeVVZMGtVV2ZZNmtVaUtFU043VXo2SmFTVmZn?oc=5","date":"2025-01-30","type":"pipeline","source":"BioWorld News","summary":"Engrail Therapeutics reports compounds for treatment of depression, schizophrenia - BioWorld News","headline":"Engrail Therapeutics reports compounds for treatment of depression, schizophrenia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBqRGFFalpsekYwa2dUNHgwYjByUE9ueFR4TGlUcWlXbnY1MWFFbDdjWmRmd3pzd3ZuWXlCTjV0YzFGMFJOaERuS0pnODZIelBNWlE1Z0lGemhxVmZ2dzVLX0NPcWRkcVc0SEVnU1FTU0E5MGZEMlB2eFhfbHozcFE?oc=5","date":"2024-04-16","type":"pipeline","source":"Business San Diego","summary":"Exclusive: Successful Biotech CEO Talks Scaling from Series A to $157M Series B - Business San Diego","headline":"Exclusive: Successful Biotech CEO Talks Scaling from Series A to $157M Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQU1IycGloN0cyZEE0Z0dwR2NMbFVxdjFmcTVqTVRVa18xT0VIV05fem5MOW03U2IxOC1oQjl5SDIwUHFJM2xCMFRIWUFLWkFkYzNRMzAzVDk3OHQxc1RUNEpBWWQxellGVzV1QnROUTI0QWtzSWxyenowa1BLN2pwSlp5bWJueHlFSjdqRzlKS1Y?oc=5","date":"2024-03-19","type":"deal","source":"BioPharma Dive","summary":"Engrail’s precision psychiatry drugs get more buy in from venture investors - BioPharma Dive","headline":"Engrail’s precision psychiatry drugs get more buy in from venture investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQZlRpQTNSaFNfam5JdldWY0RWMW5laTc1U2pReHJWNHkwVGpoazROUklmSVlhREwzRjZsd0lZT0F0TzN5RGhvS1d2d3ZOcFpObGRXQndtaEhPc3hPM2pjZ3hodDZobEtRVlc2bWZNMkFlU2JLbU9uTUJ0SG53YmxRN2FweTVwUlk2LVExMHZlRGZwaVpwTV9MY0pia1JCSmh0RjBCQm1GM2RCZW1zZ2FmSTFLM3ZxdWxRTVlyc2hUdlNxelhBajJjQ2pkVDVVSG9kQ2VXa2Zua2p0cERWS0FHdjBGb0h2QXhMU0E0VWhFdENtZDdtSll0Q2JSeWtnSU9YU25nTnNSRnA0TTdyTXdfRlZOM3FDbk1w?oc=5","date":"2024-03-19","type":"pipeline","source":"Business Wire","summary":"Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies - Business Wire","headline":"Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQODlwODNWLXp4ek9xU1JBQmRGOHExY0FfX1VNOF9nMncyd01UNWdSelRxdjJCNDBVVndSTDUzUzJZOXgxYVFuRjM4TVlNb2ZUTGZpN0hMaVBNNmdVb2Q3YVZrNEtNQnBjV2FDbFZMb1N5Skh4UlFVUWNLbnNJZlRGbjRHZGVEM1RNTmNFWDcyZVU0SkM0Z1hFTFN4R05VeDhmbGhwVDlNM3U?oc=5","date":"2024-03-19","type":"pipeline","source":"Fierce Biotech","summary":"Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry - Fierce Biotech","headline":"Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPVk1tVVJweE5HVmViNTZ3Y0ZYRkIxbTYxeTFMek1kNFluYkZEVVJaZVVBSjZjX29oVDkxeldMdGhVWm9teHptRnk3c0s5UlBTendFWVNKZS11eHNjYm9OanRuQnBLY2pvT3c2UjBrSVBsSmZicHhsOFloRFlsVllBZXI4M2lIa1JFTGtCX3FNak5MajZETTY1dVhBYzEwOFpD?oc=5","date":"2024-03-19","type":"pipeline","source":"VCCircle","summary":"Former Cipla exec's biotech startup Engrail gets $157 mn from Norwest, others - VCCircle","headline":"Former Cipla exec's biotech startup Engrail gets $157 mn from Norwest, others","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}